Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as Adjunctive Therapy to a Prostaglandin Analogue

Trial Profile

Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as Adjunctive Therapy to a Prostaglandin Analogue

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2016

At a glance

  • Drugs Brimonidine/brinzolamide (Primary) ; Brimonidine/brinzolamide (Primary)
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 28 May 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 28 Apr 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
    • 05 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top